Amputation Risk for Diabetics Camp Lejeune NC

The chances of having to have a limb amputated because of diabetes were reduced by 36 percent when people with type 2 diabetes were given the drug fenofibrate to lower their blood fat levels, new research has found.

Philip Adam ZurOwsky
(910) 450-4840
1100 Brewster Blvd
Camp Lejeune, NC
Specialty
Internal Medicine, Emergency Medicine

Data Provided by:
Richard O'neal Lynch
(910) 451-5243
119 C Street
Camp Lejeune, NC
Specialty
Family Practice

Data Provided by:
Gregory Dean Streeter
(910) 353-0565
200 Doctor Dr
Jacksonville, NC
Specialty
Family Practice

Data Provided by:
John C Gudger
(910) 577-2240
317 Western Blvd
Jacksonville, NC
Specialty
General Practice, Emergency Medicine

Data Provided by:
Ruth W Guyer
(910) 353-4991
217 Station St
Jacksonville, NC
Specialty
Family Practice

Data Provided by:
Charles Edward McCannon, MD
(301) 295-3717
Camp Lejeune, NC
Specialties
Preventive Medicine, Aerospace Medicine, General Practice
Gender
Male
Education
Medical School: Uniformed Services Univ Of The Hlth Sci, Bethesda Md 20814
Graduation Year: 1994

Data Provided by:
Takey Crist, MD
(919) 353-2115
250 Memorial Dr
Jacksonville, NC
Specialties
Obstetrics & Gynecology, General Practice
Gender
Male
Languages
Spanish, Greek
Education
Medical School: Univ Of Nc At Chapel Hill Sch Of Med, Chapel Hill Nc 27599
Graduation Year: 1965
Hospital
Hospital: Onslow Memorial Hospital, Jacksonville, Nc
Group Practice: Crist Clinic

Data Provided by:
Michael Durant Murphy
(910) 577-2360
317 Western Blvd
Jacksonville, NC
Specialty
Internal Medicine

Data Provided by:
Michael George Clarke, MD
(910) 449-6400
Jacksonville, NC
Specialties
General Practice
Gender
Male
Education
Medical School: Uniformed Services Univ Of The Hlth Sci, Bethesda Md 20814
Graduation Year: 2000

Data Provided by:
Hong-Yill Chung, MD
(910) 353-2800
PO Box 12134
Jacksonville, NC
Specialties
General Practice
Gender
Male
Education
Medical School: Korea Univ Coll Of Med, Chong-No-Ku, Seoul, So Korea
Graduation Year: 1969

Data Provided by:
Data Provided by:

Amputation Risk for Diabetics

Provided By:

THURSDAY, May 21 (HealthDay News) -- The chances of having to have a limb amputated because of diabetes were reduced by 36 percent when people with type 2 diabetes were given the drug fenofibrate to lower their blood fat levels, new research has found.

The study included 9,795 people, ages 50 to 75, who took either 200 milligrams of fenofibrate or a placebo daily for five years. The researchers reported that 115 people had lower-limb amputations attributed to diabetes.

People with previous cardiovascular disease, microvascular disease, previous non-traumatic amputation or skin ulcer, smoking and a longer duration of diabetes were more likely to have amputations than those who had other cardiovascular problems or those who had neither cardiovascular issues or amputations.

The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo. The study also found that people in the fenofibrate group had a 47 percent lower risk of amputations below the ankle and without large-vessel disease in the amputated limb. The researchers considered the status of large-vessel disease to distinguish amputations related to large-artery atherosclerosis from those related to diabetic microvascular disease.

The study found virtually no difference in the risk for amputations above the ankle between those who did and did not take fenofibrate.

Height was found to be a major predictor of amputations, with a 1.6-fold increase for every additional 10 centimeters in height.

"Classic markers of macrovascular and microvascular risk were associated with lower-extremity amputations in patients with type 2 diabetes," concluded Professor Anthony Keech, of the National Health and Medical Research Council Clinical Trials Centre at the University of Sydney, in Australia, and his colleagues.

"These findings could lead to a change in standard treatment for the prevention of diabetes-related lower-limb amputations," they concluded, adding that the results "showed a reduction in amputation rates that seemed to emerge after just 1.5 years of fenofibrate use."

The study was published this week in a special issue of The Lancet devoted to diabetes.

More information

The Amputee Coalition of America has more about diabetes and amputation.

SOURCE: The Lancet, news release, May 21, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com